NCT06551467

Brief Summary

The overall objective of this study is to evaluate the effects, feasibility, and safety of a comprehensive online Ayurveda whole-systems (WS) intervention that targets the underlying etiological factors influencing mental and physical health symptoms. The primary hypothesis is that home-based adults who participate in the Ayurveda Program for Detox and Lifestyle will experience a decrease in anxiety and depression symptoms over 4 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable anxiety

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2022

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

August 9, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 13, 2024

Completed
Last Updated

December 9, 2024

Status Verified

December 1, 2024

Enrollment Period

1.4 years

First QC Date

August 9, 2024

Last Update Submit

December 4, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Anxiety Score

    Assessed using the online standardized Patient Health Questionnaire for Somatic, Anxiety, and Depressive Symptoms (PHQ-SADS). The PHQ-SADS uses cut-off points of 5, 10, and 15 to represent mild, moderate, and severe symptoms, respectively. The assessment includes the Generalized Anxiety Disorder 7-item (GAD-7) scale, which measures the severity of anxiety. The GAD-7 uses cut-off points of 5, 10, and 15 for mild, moderate, and severe anxiety, respectively. The scale ranges from 0 to 21, with higher scores indicating greater anxiety levels.

    Assessed at baseline and once a month for four months

  • Change in Depression Score

    Assessed using the online standardized Patient Health Questionnaire for Somatic, Anxiety, and Depressive Symptoms (PHQ-SADS). The PHQ-SADS uses cut-off points of 5, 10, and 15 to represent mild, moderate, and severe symptoms, respectively. The assessment also includes the Patient Health Questionnaire-9 (PHQ-9) for depression, which uses cut-off points of 5, 10, 15, and 20 to represent mild, moderate, moderately severe, and severe depression, respectively. The PHQ-9 scale ranges from 0 to 27, with higher scores indicating greater severity of depression.

    Assessed at baseline and once a month for four months

Secondary Outcomes (3)

  • Change in Somatic or Physical Symptoms Score Change in Somatic or Physical Symptoms Score

    Assessed at baseline and once a month for four months

  • Change in Fatigue Score

    Assessed at baseline and once a month for four months

  • Changes in Body Mass Index (BMI)

    Assessed at baseline and once a month for four months

Study Arms (1)

Intervention Group

EXPERIMENTAL

The Online Ayurveda Program for Detox and Lifestyle Intervention Group will be divided into three individual psychophysiological Dosha-specific treatment groups. Participants will be assigned to these groups based on their results from the Ayurveda Dosha Self-Assessment questionnaire.

Behavioral: Online Ayurveda Program for Detox and Lifestyle

Interventions

The program includes personalized herbal remedies, detoxification procedures, dietary guidelines, yoga exercises, and daily routine practices.

Intervention Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scored ≥ 5 on the GAD-7
  • Scored ≥ 5 on the PHQ-9
  • Scored ≥ 5 on the PHQ-15
  • Age 18-80 years
  • No other psychiatric disorders
  • Not receiving specialized treatments for anxiety or depression, nor participating in another clinical trial
  • Stable psychiatric medication regimen for more than two months
  • No acute or severe medical conditions
  • Individuals who are not pregnant or breastfeeding
  • Provided informed consent

You may not qualify if:

  • Scored \< 5 on the GAD-7
  • Scored \< 5 on the PHQ-9
  • Scored \< 5 on the PHQ-15
  • Age under 18 or over 80 years
  • Other psychiatric disorders (e.g., suicidal risk)
  • Currently undergoing specialized treatments for anxiety and depression, or participating in another clinical trial
  • Psychiatric medication regimen for less than 2 months
  • Acute or severe medical condition (e.g., stroke, surgery)
  • Individuals who are pregnant or breastfeeding
  • Inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Center for Maharishi AyurVeda and Holistic Medicine

Geboltskirchen, 4682, Austria

Location

MeSH Terms

Conditions

Anxiety DisordersDepression

Interventions

detox adjuvant

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Viktoria Luhaste, PhD

    Maharishi International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This study utilized a single-arm repeated-measures design to monitor changes in the online intervention over time and increase the precision of the outcomes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Department of Physiology and Health

Study Record Dates

First Submitted

August 9, 2024

First Posted

August 13, 2024

Study Start

March 10, 2021

Primary Completion

July 25, 2022

Study Completion

July 25, 2022

Last Updated

December 9, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

The research data supporting this study's findings are not publicly accessible due to privacy and ethical constraints related to patient consent. However, anonymized data may be available from the authors upon request with permission from the institutional review board of Maharishi International University, Fairfield, Iowa.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
IPD will be available six months after the study results are published in a peer-reviewed journal and will be accessible for up to three years after that.
Access Criteria
Researchers must submit a methodologically sound proposal for review by the data-sharing committee and the institutional review board of Maharishi International University, Fairfield, Iowa. The committee will approve access, and a data use agreement must be signed prior to data release.

Locations